Clincosm LogoSign in Get a demo

Hepatitis C Infection

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
Dec 19, 2022

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed
Has Results
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
Nov 2, 2021

Hepatitis C Infection Trial in United States (MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2))

Terminated
Has Results
  • Hepatitis C Infection
  • MBL-HCV1
  • +2 more
  • Boston, Massachusetts
  • +4 more
Feb 4, 2021

Hepatitis C Infection Trial in New York (Recombivax)

Terminated
Has Results
  • Hepatitis C Infection
  • New York, New York
    Rockefeller University Hospital
Feb 20, 2020

Liver Disease and Without HIV Co-infection-Sub Study 2: HCV

Completed
  • Hepatitis C Infection
    • New York, New York
      Icahn School of Medicine
    Feb 25, 2019

    Hepatitis C Infection in World Trade Center Responders

    Completed
    • Hepatitis C Infection
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Feb 1, 2019

      Hepatitis C Infection Trial in New York (ITX 5061)

      Terminated
      • Hepatitis C Infection
      • ITX 5061
      • New York, New York
        Mount Sinai School of Medicine
      Apr 16, 2018

      Hepatitis C Infection, Viruses, Hepatocellular Carcinoma Trial in United States (Civacir® 10%)

      Completed
      • Hepatitis C Infection
      • +4 more
      • Civacir® 10%
      • Los Angeles, California
      • +22 more
      Mar 14, 2017